Proteome Sciences (LON:PRM) Shares Down 9.8% – What’s Next?

Proteome Sciences plc (LON:PRM) shares dropped 9.8% during trading on Wednesday . The company traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). Approximately 41,420 shares were traded during mid-day trading, a decline of 55% from the average daily volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).

Proteome Sciences Stock Performance

The firm has a 50-day moving average price of GBX 2.92 and a two-hundred day moving average price of GBX 3.11. The firm has a market cap of £14.17 million, a price-to-earnings ratio of -480.00 and a beta of 0.07.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.